Back to Authors

Puig, L.

0000-0001-6083-0952

A5100407307 | I2801795740

Mayo Clinic

for the Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD); and the COVID-19 Global Rheumatology

Citations 3

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

JAMA Network Open | October 20, 2021 | Volume: 4 | Issue: 10 | Pages: e2129639

10.1001/jamanetworkopen.2021.29639 | PMID 34661663

A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents

JAMA Dermatology | February 5, 2020 | Volume: 156 | Issue: 4 | Pages: 384

10.1001/jamadermatol.2019.4835 | PMID 32022846

The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy

Journal of Crohn's and Colitis | November 13, 2018 | Volume: 13 | Issue: 5 | Pages: 541-554

10.1093/ecco-jcc/jjy191 | PMID 30445584